696033

AstraZeneca Pharmaceuticals LP — FEI 2518137

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 10, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Wilmington, DE (United States)

Additional Details

Sponsor, Contract Research Organization